- State reports 227 cases, two deaths
Karnataka on Friday reported 227 new cases of COVID-19. With this, the total number of positive cases inched closer to the 30 lakh mark and stood at 29,91,369. Bengaluru Urban district recorded 147 fresh cases, the maximum across the State.
- Karnataka: Pvt unaided schools to charge 85% of tuition fees
The Karnataka government on Friday capped fees to be charged by private unaided schools for academic year 2020-21 at 85% of their tuition fees for 2019-20. No other fees like development fees, donation or charity to trusts or other facilities can be collected.
- 50% of targeted popn in Karnataka fully jabbed
Karnataka on Friday achieved a vaccination milestone with 50% of its targeted population fully vaccinated against Covid-19. Of the nearly 4.9 crore persons aged 18 years and above and identified as eligible, nearly 2.5 crore persons have been given both doses.
- No takers in pvt hosps, state goes from negative figures to wasting 0.3% doses
Private hospitals say they are struggling to exhaust the massive stock of Covid-19 vaccine doses they have in their possession and, as a result, a number of shots, especially Covishield, are being wasted. Private hospitals in Bengaluru have nearly two lakh doses of Covishield in stock, and hospital managements say there are few takers for these paid doses.
- BBMP making calls to citizens hesitating to take second dose
Civic health workers and officials have started to observe an inexplicable trend: many people who received their first shot of the COVID-19 vaccine seem to be either reluctant to take the second dose, or are delaying it.
- Kerala reports 13 norovirus cases
Thiruvananthapuram, DHNS & PTI: Wayanad district in Kerala is under the scare of norovirus infection with 13 cases being confirmed so far while around 15 more showing symptoms.
- Covaxin 77.8% effective against Covid-19: Lancet
Covaxin, the indigenous Covid-19 vaccine developed by Bharat Biotech and the Indian Council of Medical research has 77.8% efficacy against symptomatic infections, 93.4% against severe infections, and 65.2% against infection by the highly infectious Delta variant of the SARS-CoV-2 virus which causes the coronavirus disease, according to an analysis of the vaccine’s Phase 3 trials published on Friday in The Lancet.
- Delhi records 2 deaths as Covid-19 infections rise
With 62 new infections of the coronavirus disease reported in Delhi on Friday, the highest in 79 days, new cases of Covid-19 appear to have again started rising in the Capital, data shows, suggesting that the seven-month-long contraction of the outbreak in the city may be bottoming out again.
- Government nod for doorstep COVID-19 vaccination
Healthcare workers will conduct door-to-door vaccinations of eligible people across India with a special focus on districts where less than 50% of the eligible population has been vaccinated, said additional secretary, Ministry of Health and Family Welfare Manohar Agnani on Friday.
- Virus epicentre again: Europe is bringing back curbs & more
Europe has become the epicentre of the pandemic again, prompting some governments to consider reimposing unpopular lockdowns in the run-up to Christmas and stirring debate over whether vaccines alone are enough to tame Covid-19.